THRUST EN Share Price OTC Bulletin Board
Equities
TEGC
US88602Q1094
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2022 | - | Sales 2023 | 410K 34.18M | Capitalization | 353K 29.38M |
---|---|---|---|---|---|
Net income 2022 | -3M -250M | Net income 2023 | -3M -250M | EV / Sales 2022 | - |
Net Debt 2022 | 1.64M 137M | Net Debt 2023 | 1.21M 101M | EV / Sales 2023 | 3.82 x |
P/E ratio 2022 |
-1.12
x | P/E ratio 2023 |
-0.04
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Eyal Barad
FOU | Founder | 58 | 15/04/15 |
Gabriel Yariv
CHM | Chairman | 47 | 07/19/07 |
Uri Ben-Or
DFI | Director of Finance/CFO | 52 | 05/16/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eyal Barad
FOU | Founder | 58 | 15/04/15 |
Gabriel Yariv
CHM | Chairman | 47 | 07/19/07 |
1st Jan change | Capi. | |
---|---|---|
+8.38% | 115B | |
+10.13% | 105B | |
-11.69% | 22.71B | |
+2.21% | 21.83B | |
-10.88% | 18.18B | |
-41.90% | 16.52B | |
-16.00% | 16.01B | |
+2.28% | 14.14B | |
+20.54% | 10.71B |
- Stock Market
- Equities
- CNBX Stock
- TEGC Stock